S.No. | Product Name | Composition | Packing | Division |
---|---|---|---|---|
1 | Prohom Elachi Powder | Protein Powder With Dha (Kesar-elachi Flavour) | 200gm | Homogreen Pharmaceuticals |
2 | Prohom Protein Powder | Protein Powder With Dha (Choclate Flavour) | 200gm | Homogreen Pharmaceuticals |
3 | Amoxreen-d | Amoxycillin 200mg + Clavulanate Potassium 28.5mg 5ml (With Water) | 30ml | Homogreen Pharmaceuticals |
4 | Cefreen -100 | Cefixime 100mg (With Water) | 30ml | Homogreen Pharmaceuticals |
5 | Cefreen-d | Cefixime 50mg/5ml (With Water) | 30ml | Homogreen Pharmaceuticals |
6 | Homocef-100 | Cefpodoxime 100mg (With Water) | 30ml | Homogreen Pharmaceuticals |
7 | Homocef-cv | Cefpodoxime Proxetil 50mg/5ml+clavulanate (With Water) | 30ml | Homogreen Pharmaceuticals |
8 | Homocef-d | Cefpodoxime Proxetil 50mg/5ml (With Water) | 30ml | Homogreen Pharmaceuticals |
The global dry syrup market is projected to grow at a change of 6.5% between 2021 and 2028, primarily driven by the increasing demand for pediatric and antibiotic drugs, particularly for treating respiratory infections in children. This expansion is mirrored in India, where Baddi (Himachal Pradesh), home to over 300 pharmaceutical enterprises, plays an important role in both domestic and international supply chains. Moreover, many dry syrup manufacturers and suppliers in India provide third-party and pcd franchise services. This particularly allows pharmaceutical companies to enter the market without requiring significant investment in infrastructure.
In addition, technological innovation and automation are defined as automation and artificial intelligence increasingly being used in dry syrup manufacturing to improve efficiency, production speed, and dispensing precision. Moreover, the dry syrup filling machine market is expected to exceed USD 2.6 billion by 2033, growing at a change of 4.3%, owing to demand for pediatric formulas and smart production technology. Along with this, leading companies such as Homogreen Pharmaceuticals are defining the industry via dependability, scalability, and innovation.
However, some leading companies are known for their bulk WHO-GMP-certified dry syrup production. This emphasises sophisticated formulation processes and strong pharmaceutical distribution relationships.
Consequently, in India, there is a strong demand for reliable and capable dry syrup manufacturers. Thus, pediatric demand, automation, third-party manufacturing capacity, and excellent local infrastructure are key drivers of this growth (particularly in Baddi and Kala Amb).
Here we have given the list of some important working steps of our company.
The global dry syrup market is expected to rise at a change of 6.5% between 2021 and 2028, driven mostly by growing demand for pediatric and antibiotic drugs, particularly for respiratory infections in children. Hence, this market expansion is mirrored in India, where Baddi (Himachal Pradesh), home to over 300 pharmaceutical enterprises, plays an important role in both domestic and international supply chains.
Many dry syrup makers in India provide third-party and pcd franchise services. This particularly allows pharmaceutical companies to enter the market without requiring significant infrastructure investment.
Automation and artificial intelligence are increasingly being used in dry syrup manufacturing to improve efficiency, production speed, and dispensing precision. Moreover, the dry syrup filling machine market is expected to exceed USD 2.6 billion by 2033, growing at a change of 4.3%, owing to demand for pediatric formulas and smart production technology. Hence, as the top company of the pcd pharma franchise for the dry syrup range, we are defining the industry via dependability, scalability, and innovation.
Our company is always known for its bulk WHO-GMP-certified dry syrup production, which emphasises sophisticated formulation processes and strong pharmaceutical distribution relationships. Also, specialise in third-party production and combine innovation, regulatory compliance, and scalable operations.
Here are the main benefits of dry syrups that make them popular in the Indian pharma market:
1. Longer shelf life:
Being in powder/granule form, dry syrups remain stable for a longer period compared to liquid syrups. This moisture-free packaging prevents degradation.
2. Convenient for storage & transport:
Lightweight and compact compared to liquid syrups, and are also easy to transport, with less risk of leakage or breakage.
3. Better stability of ingredients:
Some drugs are unstable in liquid form but stable as a dry powder, and are also reconstituted at the time of use to ensure maximum potency.
4. Pediatric-friendly:
These are specially formulated for children who cannot swallow tablets or capsules. These are available in flavoured versions (strawberry, orange, etc.) To improve taste and compliance.
5. Ease of dose adjustment:
This can be easily measured using spoons, cups, or droppers once reconstituted. These are suitable for flexible dosing in paediatrics and geriatrics.
6. Cost-effective:
Less packaging and storage cost than liquids, and also a longer shelf life, reduces wastage.
Pharmaceutical investors in India who want to invest in a genuine PCD Pharma franchise for dry syrups in India consistently choose our organisation. Because here, they may acquire expert and market-oriented services to assist them in building their enterprises. First, we discuss our advanced infrastructure units. We have extensive infrastructure in our industrial facilities.
Here we have installed the latest machinery to produce high-quality medicines in a short period of time. In addition, our competent logistical team and production facilities in tax-free zones play an important role in enabling us to do so. Furthermore, we have the best team of manufacturing specialists who are dedicated to their duties. They are extremely competent workers, particularly in the industrial sector. They understand how to complete a large number of orders in a specific amount of time.
In addition, our logistics staff ships the entire order fast and delivers it to our consumers. As a result, it is one of the most crucial factors influencing our clients’ decision to choose our dry syrup pcd company in India. In addition, we offer marketing and promotional help to our franchise customers. This comprises product information, samples, visual aids, promotional items, and marketing materials.
As a result, our team’s expertise helps them increase brand awareness and build their business. Aside from that, customers who acquire our pharma franchise for dry syrup always benefit from our 24-hour customer service. For this service, we have specifically hired professional people who are well-equipped to manage repeated inquiries with a rapid response time to the franchise. Hence, the various aspects make us the best selection of pcd franchisees’ services across India.
Consequently, Homogreen Pharmaceuticals is the leading platform of one of the top genuine dry syrup manufacturer and supplier in India. Here, you can not only get the trusted manufacturing and supply services, but also get the pcd franchisee services. Thus, to get the benefits of the wonderful business opportunities, please join us.